Blood cancer treatment breakthrough with gene editing

Scientists in Australia are using CRISPR technology, which allows them to edit out specific genes to open up the treatment options for people with blood cancer. Professor Marco Herold and his team at the Olivia Newton-John Cancer Research Institute have been focused on helping patients who're resistant to lymphoma drugs, and now, they think they've achieved something that could help alleviate the lives of millions of people.